|
Archived NCCN Tumor Boards: Induction Therapy for Ph+ B-Cell Acute Lymphoblastic Leukemia |
1.00 |
10/13/2026 - 12:00am to 10/08/2027 - 11:59pm |
|
NCCN Tumor Boards: Advances in the Management of Early-Stage and Locally Advanced Cervical Cancer |
1.00 |
10/21/2026 - 12:00am to 04/04/2027 - 11:59pm |
|
NCCN Tumor Boards: Select Updates in the Treatment of Multiple Myeloma |
1.00 |
10/21/2026 - 12:00am to 02/21/2027 - 11:59pm |
|
Recorded Presentation of NCCN Optimizing Patient Outcomes - Management of Bispecific T-Cell Engager Toxicities: How to Balance Increased Efficacy... |
1.00 |
10/27/2026 - 12:00am to 10/16/2027 - 11:59pm |
|
Module 1: Foundations of Cancer-Related Pain |
1.00 |
10/30/2026 - 12:00am to 10/29/2027 - 11:59pm |
|
Module 2: Multimodal Management of Cancer Pain |
1.00 |
10/30/2026 - 12:00am to 10/29/2027 - 11:59pm |
|
Module 3: Safe and Effective Use of Opioid Analgesics in Cancer Care |
1.00 |
10/30/2026 - 12:00am to 10/29/2027 - 11:59pm |
|
Module 4: Managing Complexity: Substance Use Disorders and Referral in Cancer Pain |
1.00 |
10/30/2026 - 12:00am to 10/29/2027 - 11:59pm |
|
Comprehensive Pain Management in Oncology: A Multidisciplinary Approach - Tumor Boards |
|
10/30/2026 - 12:00am to 10/29/2027 - 11:59pm |
|
Individualizing Treatment for Patients with Waldenström Macroglobulinemia |
0.50 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
|
Erdheim-Chester Disease: The Role of Molecular Testing in Treatment Planning |
0.75 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
|
The Evolving Treatment Landscape in Myeloproliferative Neoplasms |
0.50 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
|
Advances in Systemic Mastocytosis |
0.75 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
|
Treating Adult Patients with Burkitt Lymphoma |
0.50 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
|
Psychosocial Support for Adolescent and Young Adult Patients with Hematologic Malignancies |
0.75 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
Facebook
X
LinkedIn
Forward